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This is the first case of NBAS disease detected by NBS for primary immunodeficiency.
NBS with KRECs is revealing unknown potentialities detecting conditions that benefit
from early recognition like NBAS deficiency. Immune phenotyping should be mandatory
in patients with NBAS deficiency since they can exhibit severe immunodeficiency with
hypogammaglobulinemia as the most frequent finding. Fever during infections is a known
trigger of acute liver failure in this syndrome, so immune dysfunction, should never go
unnoticed in NBAS deficiency in order to start adequate therapy and prophylaxis.
Keywords: KREC, newborn screening, immunodeficiency, NBAS, neuroblastoma amplified sequence deficiency,
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BACKGROUND
Neuroblastoma amplified sequence (NBAS) deficiency is a very rare disease characterized by
an extremely broad spectrum of phenotypes (1). Clinical features range from isolated recurrent
episodic liver failure, precipitated by intercurrent febrile illness, to multisystemic syndrome,
which includes short stature, skeletal osteopenia and dysplasia, optic atrophy, immunological
abnormalities, and autoimmune disorders (2). NBAS is a highly conserved gene encoding for a
component of the syntaxin-18 complex, a component of an endoplasmic reticulum (ER) tethering
complex involved in the Golgi–ER retrograde transport of vesicles (3). Thermal susceptibility of the
syntaxin-18 complex is the basis of fever dependency of liver failure episodes and could be involved
in the possible pathogenic mechanism of NBAS mutations.
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In this paper, we report the first case of NBAS deficiency
identified in the context of a newborn screening (NBS)
program for primary immunodeficiencies (PIDs) with κ-deleting
recombination excision circles (KRECs) quantification on dried
blood spot. We also focus on the immunological spectrum of the
disease with a review of immunological cases in the literature.
CASE PRESENTATION
The patient is a male newborn of Pakistani origin, son
of consanguineous parents (Figure S1—Supplementary
Material section), born by scheduled cesarean section at 36
weeks of gestational age, with severe intrauterine growth
restriction (−3DS) and blood flow abnormalities at a prenatal
Doppler ultrasonography.
The patient came to our attention due to the complete
absence of KRECs and normal TRECs on DBS (dried blood
spot) while hospitalized for low weight at birth (1,520 g),
intolerance for enteral feeding, hepatosplenomegaly, slightly
elevated liver transaminase, head and face eczematous dermatitis,
and persistent Rotavirus enteritis. During the 1st month, he
also presented Klebsiella pneumoniae urinary tract infection
and methicillin-resistant Staphylococcus aureus sepsis. Peculiar
phenotypic features including triangular face, proptosis, flat
philtrum, mild retrognatia, hirsutism, loose and slightly wrinkled
skin, and apparent reduction of subcutaneous fat were noticed
at birth. Complete blood count showed lymphocytopenia out of
infectious episodes, marked hypereosinophilia, and a low platelet
count with normal mean volume. Serum immunoglobulin G
(IgG) were markedly decreased, IgA and IgM were undetectable,
and levels of IgE were slightly augmented (Table 1). Extended
phenotyping of the immune systemwas carried out on peripheral
blood (Table 1, Figure 1) and confirmed on whole blood
the normal expression of TRECs and the complete absence
of KRECs, complete absence of CD19+ cells, low count of
CD8+ lymphocytes, and reduced natural killer (NK) levels
(Table 1, Figure 1). Classical and leaky forms of severe combined
immunodeficiency were excluded by normal proliferation
response of T cells to mitogens. Maternal engraftment of T
lymphocytes was excluded by the normal representation of
naïve T cells and by the different HLA-I typing and karyotypes
of mother and son. The T cell receptor (TCR) repertoire
expressed normal variability. Flow cytometric analysis showed
normal expression of BTK (Bruton tyrosine kinase) protein
on monocytes (Figure S2—Supplementary Material section)
and normal expression of wasp protein on lymphocytes and
monocytes. Regulatory T cells were normally represented among
T CD4+ lymphocytes (Table 1). A colonoscopy was carried
out for persistent diarrhea and reduced tolerance to enteral
feeding. The histological examination of mucosal intestinal
biopsies showed an absence of plasma cells and reduced
representation of T lymphocytes, suggesting immunodeficiency
Abbreviations:NBAS, neuroblastoma amplified sequence; TRECs, T-cell receptor
excision circles; KRECs, κ-deleting recombination excision circles; SOPH, short
stature with optic atrophy and Pelger–Huët anomaly syndrome; ILFS2, type 2
infantile hepatic impairment.
but not autoimmune enteropathy. Molecular analysis for genome
detection of adenovirus, rotavirus, EBV, CMV, and enterovirus
were carried out on intestinal biopsies and no viral copies were
detected. As a syndromic picture was suspected, clinical exome
was performed by Next Generation Sequencing and identified
a homozygous variant in NBAS (NM_015909): c. [1948C>
T], p.Pro650Ser, inherited from both parents (Figure S1—
Supplementary material section). This variant has not been
described in the literature and is reported as rs558233705 with
a low allele frequency in the Asian population in principal
exome and genome databases (https://www.ncbi.nlm.nih.gov/
snp/rs558233705#frequency_tab. Last visit on 05 February 2019).
To investigate the NBAS mutation-based disease features
associated, total body X-ray was performed and revealed slightly
bilateral brachydactilia of the 5th finger.
Immunoglobulin substitutive therapy and antimicrobial
prophylaxis were promptly started during the 1st days of
life. At the age of 3 months, due to the persistence of
clinical manifestations with severe growth restriction and severe
eczematous dermatitis, corticosteroid therapy was introduced
with rapid improvement of gastrointestinal and cutaneous
manifestations and the almost immediate reduction of peripheral
hypereosinophilia. Steroid tapering was attempted unsuccessfully
and caused re-exacerbation of gastrointestinal symptoms which,
at 7 months of age, still constitute the most consistent clinical
finding, together with severe growth restriction.
MATERIALS AND METHODS
Written informed consent has been obtained from the legal
representatives of the patient for the publication of this
case report.
NEWBORN SCREENING FOR PRIMARY
IMMUNODEFICIENCY WITH KRECS
The forward, reverse primers and probes for KRECs were
designed in our laboratory using Primer Express software
version 3.0 (Applied Biosystems). Primer specificity was assessed
by BLAST search (http://www.ncbi.nlm.nih.gov/blast/), which
confirmed their uniqueness. TREC and KREC levels were
normalized per microliter of blood, assuming that the sample
contains approximately 3 µl of whole blood. Calibration
curves were generated by means of 10-fold serial dilution of
plasmids that contain TREC, KREC, and β-actin sequences.
Diagnostic cutoff scores were established at 25 TRECs/µl
and 10 KRECs/µl, according to the values reported in
literature (4).
WHOLE-EXOME SEQUENCING
Exomes of the patient and his parents were captured from the
genomic DNA using SeqCap EZMedExome (Roche NimbleGen)
and sequencing was carried out using the NextSeq Illumina
platform. The alignment of the reads (BWA), the call of
the variants (GATK), the annotation (Annovar), and the
Frontiers in Immunology | www.frontiersin.org 2 August 2019 | Volume 10 | Article 1955
Ricci et al. NBAS Deficiency as Inborn Errors of Immunity
TABLE 1 | Patient’s immune phenotyping at different ages.
Age 1 month and 20 days 2-months 3-months 4-months 5-months 6-months 7-months
Lymphocyte count (cells/mcL) (% of WB)
Lymphocyte subtypes (cells/mcL) (% of
lymphocytes)
2,813 (16,1%) 3,112 (18.5%) 714 (10%) 1,550 (21%) 1,835 (20%) 2,081 (15.1%) 638 (8.8%)
CD19+ 4 (0%) 7 (0%) 3 (0%) 0 (0%) 0 (0%) n.a. n.a.
CD3+ 2,348 (88%) 4,428 (95%) 1,963 (97%) 1,860 (95%) 1,575 (95%) n.a. n.a.
CD3+CD4+ 2,127 (80%) 3,714 (79%) 1,396 (69%) 1,396 (72%) 1,370 (83%) n.a. n.a.
CD3+CD8+ 189 (7%) 566 (12%) 389 (19%) 401 (21%) 186 (11%) n.a. n.a.
CD3−CD16+CD56+ 261 (10%) 193 (4%) 43 (2%) 72 (4%) 60 (4%) n.a. n.a.
CD4+/CD8+ ratio 11.4 6.6 3.6 3.4 7.5 n.a. n.a.
Specific lymphocyte counts (% of CD4+)
CD45RA+ 78% n.a. n.a. n.a. n.a. n.a. n.a.
CD45RO+ 22% n.a. n.a. n.a. n.a. n.a. n.a.
CD25+CD127Low n.a. 6.7 (n.r. 4–16) n.a. n.a. n.a. n.a. n.a.
Mitogen stimulation
PHA 85 (n.v. > 80) n.a. n.a. n.a. n.a. n.a. n.a.
IL-2 83 (n.v. > 80) n.a. n.a. n.a. n.a. n.a. n.a.
Serum immunoglobulins
IgG (mg/dl) 325 213 n.a. 182 252 307 539
IgA (mg/dl) <7.83 <7.83 n.a. <7.83 <7.83 <7.83 8.2
IgM (mg/dl) 24 34 n.a. <52.5 35 32 18
IgE (kU/L) 108 11 n.a. n.a. n.a. n.a. n.a.
n.a., not available; n.v., normal values.
FIGURE 1 | Flow cytometric assessment of lymphocyte subsets in healthy control and in our patient (age matched) that show for our patient absence of B cells
(CD19+), low CD8+ and NK cells.
prioritization of the variants were performed with strategies
developed in-house according to the guidelines of the American
College of Medical Genetics and Genomics (ACMG). The
data obtained were filtered according to the patient’s clinical
phenotype. A homozygous variant in NBAS (NM_015909):
c.1948C > T, inherited from both parents, was identified. The
1948C > T variant leads to the substitution of hydrophobic
proline 650 with polar serine (p.Pro650Ser).
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DISCUSSION
This is the first reported case of the NBAS mutation-based
disease detected by NBS for PIDs with KRECs quantification
on DBS. Bi-allelic mutations in the NBAS gene cause a wide
range of phenotypes, including hepatic, skeletal, ocular, and
immunologic abnormalities. T-cell receptor excision circles
(TRECs) and KRECs are used worldwide for detection of T or
FIGURE 2 | Representation of 73 patients reported in literature (1, 6, 8–22).
60% of patients (gray area) did not undergo complete immune
characterization. 44% of patients who underwent immune characterization
presented an immunological impairment (red area).
B cell lymphopenia in newborns. As previously described (5),
Tuscany is the only region in Italy to have implemented an NBS
for PIDs with TREC and KREC quantification on DBS through
multiplex real-time PCR (polymerase chain reaction). By January
2019, 38,300 children had been screened. The implementation
and use of NBS for PIDs with TREC and KREC in a large-
scale population are revealing otherwise unknown potentialities
of the method. Not only does it allow the identification of
known cellular and humoral PIDs, but it also permits the
detection of clinically severe congenital conditions that benefit
from early recognition and that are variably associated with
immunodeficiency, such as NBAS deficiency. NBAS mutation-
based disease has been associated with two main clinical
phenotypes: the infantile liver failure syndrome 2 (ILFS2) and
short stature with optic atrophy and Pelger–Huët anomaly
syndrome (SOPH) (2, 6). The liver phenotype in NBAS deficiency
is most typically a recurrent acute liver failure, triggered by
febrile infections. The molecular pathogenesis by which an
NBAS defect contributes to fever-dependent liver disease is
not fully understood. The NBAS protein is thought to be
involved in Golgi-to-ER retrograde vesicular trafficking and to
control non-sense-mediated mRNA decay (7). A knockdown
of NBAS in HeLa cells led to a defective protein glycosylation
(3). Staufner et al. described how fibroblasts of patients with
bi-allelic NBAS mutations showed an increased susceptibility
to high temperatures at the protein and functional levels,
causing an impaired transport between Golgi-to-ER retrograde
vesicular trafficking. They suggested that raised temperatures
themselves may be the starting point of ER stress-induced liver
FIGURE 3 | Representation of clinical and laboratory immunological findings (Y-axis) reported among 14 patients (X-axis) who presented a known immunological
impairment (including the current case).
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cell apoptosis that lead to fever-dependent ALF (acute liver
failure) (1).
For the time being, our patient has not presented episodes
of ALF, but persistent elevations of transaminase have been
detected (Figure S3—Supplementary material section) with
normal cholestasis values and coagulation function. The last
abdominal ultrasound evaluation (performed during his 7th
month) revealed liver of fairly increased size associated with
preserved biliary tract features and liver echostructure. He
presents facial dimorphisms and slight bilateral brachydactyly
of the 5th finger, but no optical atrophy and no Pelger–
Huët anomalies have been identified. Due to his young age,
it is still difficult to determine whether the clinical phenotype
tends toward ILFS2 or to SOPH. As in two previously
described cases (8), the immunological impairment, associated
with the gastrointestinal dysfunction, seems to be predominant
in the global clinical picture of our patient. The literature
reviewed revealed that, in more than half of the patients
with NBAS deficiency, immune characterization is completely
unknown (Figure 2) or partial (1, 6, 8–22). In particular,
a complete absence of B cells has never been described in
NBAS deficiency, but recurrent/chronic viral infections, severe
hypogammaglobinemia, and a reduced number of B cells are
the most frequently described immune anomalies in patients
with NBAS deficiency (Figure 3) (1, 6, 8–22). Moreover, a
reduced number of normally functional NK cells, altered
CD4+/CD8+ ratio with reduced CD8+ numbers and hyper-IgE,
have been previously described and are present in our patient
(Figure 3). Our patient seems to possess the whole range of
immune alterations hitherto described in previous cases, thus
exhibiting the most severe immune phenotype ever reported in
NBAS deficiency.
Immunodeficiency, associated with the NBAS phenotype,
contributes to recurrent infections and abnormal liver enzymes
with fever. Furthermore, since fever is a known trigger
of acute liver failure, immune dysfunction, even if mild,
should never go unnoticed in NBAS deficiency. In particular,
hypogammaglobinemia is the most frequent immunological
feature associated with NBAS deficiency (Figure 3) (1, 6, 8–
22); thus, these patients may benefit from replacement therapy
with immunoglobulin in order to reduce the rate of infections
and the consequent risk of acute liver failure. We suggest that
extended immune phenotyping should be mandatory in all these
patients in order to collect and exchange data regarding a disease
whose characterization is still being unfolding. In fact, basing on
previously reported NBAS cases in literature, it is not possible
to define a clear genotype–phenotype correlation regarding
immunological involvement in this syndrome (Figure S4)
(1, 6, 8–22). The phenotype classification for PID outlined by
the International Union of Immunological Societies (IUIS)
already includes NBAS deficiency among inborn errors of
immunity (23). If the high frequency of hypogammaglobinemia
in NBAS deficiency is confirmed (Figure 2), the authors feel
that inclusion among prevalent antibody deficiencies could be of
even greater support for the clinicians facing such a challenging
diagnostic process. The potential mechanism of NBASmutations
affecting the immune system is still unknown. Further in-
depth functional studies on Golgi-to-ER retrograde vesicular
trafficking in immune cells of affected patients are needed to
establish the genotype–phenotype correlations and to reveal the
pathogenesis of the wide immunological phenotypic spectrum of
the NBAS disease.
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